A Phase I Study Using Single Agent Birinapant in Patients with Relapsed Myelodysplastic Syndrome and Acute Myelogenous LeukemiaNoelle V. Frey, Martin Carroll, John H. Baird et al.|Blood|2014Cited by 14
Clofarabine Busulfan Conditioning Improves Outcomes in Patients with Active Acute Myelogenous Leukemia Undergoing Allogeneic Stem Cell TransplantAlexis Zebrowski, Noelle V. Frey, Alexandra L. Hanlon et al.|Blood|2014Cited by 5
Clofarabine and Busulfan Myeloablative Conditioning in Allogeneic Hematopoietic Cell Transplantation for Patients With Active Myeloid MalignanciesMatthew P. Connor, Noelle V. Frey, Alison W. Loren et al.|Transplantation and Cellular Therapy|2022Cited by 3